Abstract
Early clinical trials indicate that it is possible to immunize children with live attenuated measles virus. The susceptible subjects develop either no symptoms at all or a modified measles with fever, leukopenia, and a faint eruption. Koplik spots are uncommon. These children have no catarrhal symptoms and do not appear toxic. All of the susceptible children developed a significant titer of neutralizing antibodies. No complications occurred in any of our cases. The urgent need of a measles vaccine is stressed, and there are indications that measles immunization as a routine procedure may not be too distant. Early clinical trials indicate that it is possible to immunize children with live attenuated measles virus. The susceptible subjects develop either no symptoms at all or a modified measles with fever, leukopenia, and a faint eruption. Koplik spots are uncommon. These children have no catarrhal symptoms and do not appear toxic. All of the susceptible children developed a significant titer of neutralizing antibodies. No complications occurred in any of our cases. The urgent need of a measles vaccine is stressed, and there are indications that measles immunization as a routine procedure may not be too distant.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
